social anxiety disorder. Social phobias
Conditions
Interventions
Intervention 1: Intervention group: A group of 15 people with acquired immunodeficiency disease. The research and intervention process is as follows: First, the pre-test stage by distributing a questi
Sponsors
Tehran University of Medical Sciences
Int. Academy of NLP & Coching prof.Omraie
Eligibility
Sex/Gender
All
Age
10 Years to 70 Years
Inclusion criteria
Inclusion criteria: Acquired immunodeficiency virus Having social anxiety disorder
Exclusion criteria
Exclusion criteria: Patients with acquired immunodeficiency disease for less than (3) three years. Affected individuals whose daily functioning and hope for the future and self-efficacy are not impaired.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Social Anxiety Score. Timepoint: At the beginning of the study (before the intervention) and 3 months after the intervention. Method of measurement: Quality of Life Questionnaire, Social Anxiety, Death Anxiety, Resilience and Hardiness Scale.;Quality of Life. Timepoint: At the beginning of the study (before the intervention) and 3 months after the intervention. Method of measurement: Connor Social Panic Questionnaire (SPIN) and Quality of Life Questionnaire (SF-12) Short Form, Templer Death Anxiety Scale Questionnaire, Connor and Davidson Resilience Scale Questionnaire CD-RISC and Ahvaz Stubbornness Questionnaire 27. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHosein Alizadeh Barough
Islamic Azad University
Outcome results
None listed